MedPath

Tasipimidine

Generic Name
Tasipimidine

Efficacy and Tolerability of Tasipimidine in Sleepless Patients

Phase 2
Recruiting
Conditions
Insomnia
Interventions
Drug: Tasipimidine placebo
First Posted Date
2025-05-04
Last Posted Date
2025-05-04
Lead Sponsor
Orion Corporation, Orion Pharma
Target Recruit Count
153
Registration Number
NCT06956495
Locations
🇫🇮

Terveystalo Helsinki Uniklinikka, Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath